{"id":"https://openalex.org/W2139782290","doi":"https://doi.org/10.1155/2008/520465","title":"Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head\u2010to\u2010Head Randomized Clinical Studies","display_name":"Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head\u2010to\u2010Head Randomized Clinical Studies","alternate_titles":[],"publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2139782290","doi":"https://doi.org/10.1155/2008/520465","mag":"2139782290","pmid":"https://pubmed.ncbi.nlm.nih.gov/18769492","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2519139"},"language":"en","primary_location":{"id":"doi:10.1155/2008/520465","doi":"https://doi.org/10.1155/2008/520465","is_oa":true,"landing_page_url":"https://doi.org/10.1155/2008/520465","pdf_url":"https://downloads.hindawi.com/journals/ppar/2008/520465.pdf","source":{"id":"https://openalex.org/S71649485","display_name":"PPAR Research","issn_l":"1687-4757","issn":["1687-4757","1687-4765"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319869","host_organization_name":"Hindawi Publishing Corporation","host_organization_lineage":["https://openalex.org/P4310319869","https://openalex.org/P4310320595"],"host_organization_lineage_names":["Hindawi Publishing Corporation","Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PPAR Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139782290"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://downloads.hindawi.com/journals/ppar/2008/520465.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057449551","display_name":"Mark A. Deeg","orcid":"https://orcid.org/0000-0001-6920-9396","observed_orcids":["https://orcid.org/0000-0001-6920-9396"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Mark A. Deeg","raw_affiliation_strings":["Endocrine Research and Clinical Investigation, Lilly Research Laboratories, Eli Lilly & Co., Indianapolis, IN 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrine Research and Clinical Investigation, Lilly Research Laboratories, Eli Lilly & Co., Indianapolis, IN 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016547950","display_name":"Meng Hee Tan","orcid":"https://orcid.org/0000-0001-6674-2611","observed_orcids":["https://orcid.org/0000-0001-6674-2611"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Meng H. Tan","raw_affiliation_strings":["Endocrine Research and Clinical Investigation, Lilly Research Laboratories, Eli Lilly & Co., Indianapolis, IN 46285, USA lilly.com","#N##TAB##TAB##TAB##TAB# Eli Lilly and Company#N##TAB##TAB##TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrine Research and Clinical Investigation, Lilly Research Laboratories, Eli Lilly & Co., Indianapolis, IN 46285, USA lilly.com","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"#N##TAB##TAB##TAB##TAB# Eli Lilly and Company#N##TAB##TAB##TAB#","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5057449551"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":{"value":1630,"currency":"USD","value_usd":1630},"apc_paid":{"value":1630,"currency":"USD","value_usd":1630},"fwci":0.9734,"has_fulltext":true,"cited_by_count":54,"citation_normalized_percentile":{"value":0.70012657,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"2008","issue":"1","first_page":"520465","last_page":"520465"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12975","display_name":"Paraoxonase enzyme and polymorphisms","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":1.0},{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":1.0},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9900000095367432},{"id":"https://openalex.org/keywords/ppargamma-agonists","display_name":"PPAR\u03b3 agonists","score":0.9139999747276306},{"id":"https://openalex.org/keywords/lipid-metabolism","display_name":"lipid metabolism","score":0.7850000262260437},{"id":"https://openalex.org/keywords/lipoproteins","display_name":"lipoproteins","score":0.9589999914169312},{"id":"https://openalex.org/keywords/apolipoproteins","display_name":"apolipoproteins","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9829999804496765},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.9049999713897705},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5759999752044678},{"id":"https://openalex.org/keywords/randomized-controlled-trials","display_name":"randomized controlled trials","score":0.6850000023841858}],"concepts":[{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.9573688507080078},{"id":"https://openalex.org/C2776923340","wikidata":"https://www.wikidata.org/wiki/Q1393556","display_name":"Thiazolidinedione","level":4,"score":0.8735989332199097},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.8570109605789185},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.8115115165710449},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6525751352310181},{"id":"https://openalex.org/C4733338","wikidata":"https://www.wikidata.org/wiki/Q2792936","display_name":"Lipid metabolism","level":2,"score":0.6352514028549194},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5119246244430542},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4918675422668457},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.47024932503700256},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.46003469824790955},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.36470621824264526},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.35614240169525146},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.314111590385437}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1155/2008/520465","doi":"https://doi.org/10.1155/2008/520465","is_oa":true,"landing_page_url":"https://doi.org/10.1155/2008/520465","pdf_url":"https://downloads.hindawi.com/journals/ppar/2008/520465.pdf","source":{"id":"https://openalex.org/S71649485","display_name":"PPAR Research","issn_l":"1687-4757","issn":["1687-4757","1687-4765"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319869","host_organization_name":"Hindawi Publishing Corporation","host_organization_lineage":["https://openalex.org/P4310319869","https://openalex.org/P4310320595"],"host_organization_lineage_names":["Hindawi Publishing Corporation","Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PPAR Research","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2519139","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2519139/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2519139/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PPAR Res","raw_type":"Text"},{"id":"pmid:18769492","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18769492","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PPAR research","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:acef94914b6e4c75ae4c3f1113409cde","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/acef94914b6e4c75ae4c3f1113409cde","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PPAR Research, Vol 2008 (2008)","raw_type":"article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.274.5317","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.274.5317","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/97/96/PPAR_Res_2008_Aug_21_2008_520465.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1155/2008/520465","doi":"https://doi.org/10.1155/2008/520465","is_oa":true,"landing_page_url":"https://doi.org/10.1155/2008/520465","pdf_url":"https://downloads.hindawi.com/journals/ppar/2008/520465.pdf","source":{"id":"https://openalex.org/S71649485","display_name":"PPAR Research","issn_l":"1687-4757","issn":["1687-4757","1687-4765"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319869","host_organization_name":"Hindawi Publishing Corporation","host_organization_lineage":["https://openalex.org/P4310319869","https://openalex.org/P4310320595"],"host_organization_lineage_names":["Hindawi Publishing Corporation","Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PPAR Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2139782290.pdf","grobid_xml":"https://content.openalex.org/works/W2139782290.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W71678318","https://openalex.org/W1522960617","https://openalex.org/W1523312932","https://openalex.org/W1968973887","https://openalex.org/W1971172093","https://openalex.org/W1972136146","https://openalex.org/W1977188464","https://openalex.org/W1978021168","https://openalex.org/W2008497553","https://openalex.org/W2016183600","https://openalex.org/W2017421207","https://openalex.org/W2039401819","https://openalex.org/W2057271976","https://openalex.org/W2059101048","https://openalex.org/W2066299453","https://openalex.org/W2072664557","https://openalex.org/W2074047111","https://openalex.org/W2077428021","https://openalex.org/W2091220511","https://openalex.org/W2092831846","https://openalex.org/W2102469433","https://openalex.org/W2102675827","https://openalex.org/W2115088256","https://openalex.org/W2117205405","https://openalex.org/W2124241212","https://openalex.org/W2127125241","https://openalex.org/W2131215476","https://openalex.org/W2131702141","https://openalex.org/W2132525699","https://openalex.org/W2133846768","https://openalex.org/W2149433053","https://openalex.org/W2156248522","https://openalex.org/W2159969745","https://openalex.org/W2162646492","https://openalex.org/W2165149014","https://openalex.org/W2165947313","https://openalex.org/W2166226788","https://openalex.org/W2169582126","https://openalex.org/W2415560646","https://openalex.org/W4240449862"],"related_works":["https://openalex.org/W1988232808","https://openalex.org/W2049571309","https://openalex.org/W2009004494","https://openalex.org/W2037455506","https://openalex.org/W2021208588","https://openalex.org/W2372604336","https://openalex.org/W2102675827","https://openalex.org/W2124880104","https://openalex.org/W2166665398"],"abstract_inverted_index":{"Peroxisome":[0],"proliferator-activated":[1],"receptors":[2],"(PPARs)":[3],"play":[4],"an":[5],"important":[6],"role":[7],"in":[8,74],"regulating":[9],"both":[10,17],"glucose":[11,34],"and":[12,19,27,67],"lipid":[13,40,57],"metabolism.":[14,41],"Agonists":[15],"for":[16],"PPARgamma":[18,20,36,64],"have":[21],"been":[22],"used":[23],"to":[24,32],"treat":[25],"dyslipidemia":[26],"hyperglycemia,":[28],"respectively.":[29],"In":[30,42],"addition":[31],"affecting":[33],"metabolism,":[35],"agonists":[37],"also":[38],"regulate":[39],"this":[43],"review,":[44],"we":[45],"will":[46],"focus":[47],"on":[48],"the":[49,56,60],"randomized":[50],"clinical":[51],"trials":[52],"that":[53],"directly":[54],"compared":[55],"effects":[58],"of":[59,63],"thiazolidinedione":[61],"class":[62],"agonists,":[65],"pioglitazone":[66],"rosiglitazone,":[68],"head-to-head":[69],"either":[70],"as":[71],"monotherapy":[72],"or":[73,79],"combination":[75],"with":[76],"other":[77],"lipid-altering":[78],"glucose-lowering":[80],"agents.":[81]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139782290","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
